Coronavirus disease 2019 in Latin American patients with multiple sclerosis

Simple item page
dc.catalogadorjwg
dc.contributor.authorFragoso, Yara D.
dc.contributor.authorSchiavetti, Irene
dc.contributor.authorCarmisciano, Luca
dc.contributor.authorPonzano, Marta
dc.contributor.authorSteinberg, Judith
dc.contributor.authorTrevino Frenk, Irene
dc.contributor.authorCiampi, Ethel
dc.contributor.authorVecino, Maria Cecilia A.
dc.contributor.authorCorrea, Edgar P.
dc.contributor.authorCarcamo Rodriguez Claudia Andrea
dc.contributor.authorGomes, Sidney
dc.contributor.authorPimentel, Maria Lucia V.
dc.contributor.authorSantos, Gutemberg A. C.
dc.contributor.authorVrech, Carlos
dc.contributor.authorWinckler, Thereza C. A.
dc.contributor.authorSormani, Maria Pia
dc.date.accessioned2024-01-19T15:55:07Z
dc.date.available2024-01-19T15:55:07Z
dc.date.issued2021
dc.description.abstractPatients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic.
dc.fechaingreso.objetodigital2024-12-18
dc.format.extent3 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.msard.2021.103173
dc.identifier.eissn2211-0356
dc.identifier.issn2211-0348
dc.identifier.pubmedidMEDLINE:34332462
dc.identifier.urihttps://doi.org/10.1016/j.msard.2021.103173
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/80770
dc.identifier.wosidWOS:000703960600023
dc.information.autorucEscuela de Medicina; Carcamo Rodriguez Claudia Andrea; 0000-0002-9430-216X; 562
dc.language.isoen
dc.nota.accesocontenido parcial
dc.publisherELSEVIER SCI LTD
dc.revistaMULTIPLE SCLEROSIS AND RELATED DISORDERS
dc.rightsacceso restringido
dc.subjectMultiple sclerosisPandemicCOVID-19rituximabocrelizumab
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleCoronavirus disease 2019 in Latin American patients with multiple sclerosis
dc.typeartículo
dc.volumen55
sipa.codpersvinculados562
sipa.trazabilidadWOS;18-03-2022
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Coronavirus disease 2019 in Latin American patients with multiple sclerosis.pdf
Size:
2.52 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas